Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
breast neoplasms
MeSH D001943 - breast neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001941:
Breast diseases
1 Company
1 Drug
$
Success rate
D009371:
Neoplasms by site
0 Companies
0 Drugs
Success rate
D001943:
Â
Breast neoplasms
197 Companies
87 Drugs
$
Success rate
D000069584:
Unilateral breast neoplasms
0 Companies
0 Drugs
Success rate
D000071960:
Breast carcinoma in situ
0 Companies
0 Drugs
Success rate
D018270:
Ductal carcinoma breast
0 Companies
0 Drugs
Success rate
D018275:
Lobular carcinoma
0 Companies
0 Drugs
Success rate
D018567:
Male breast neoplasms
1 Company
1 Drug
$
Success rate
D058922:
Inflammatory breast neoplasms
0 Companies
0 Drugs
Success rate
D061325:
Hereditary breast and ovarian cancer syndrome
0 Companies
0 Drugs
Success rate
D064726:
Triple negative breast neoplasms
2 Companies
3 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
80
%
337/422
Phase 2
41
%
216/525
Phase 3
52
%
182/349
Approved:
78
Overall Success rate:
17%
All Clinical Trials
No data
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use